Lee S. Rosen, M.D.
Dr. Lee Rosen directs the Developmental Therapeutics Program at Premiere Oncology, affiliated with the John Wayne Cancer Institute and Saint John’s Health Center in Santa Monica, California. He was formerly an Assistant Professor in the Division of Hematology-Oncology, Department of Medicine at the University of California, Los Angeles, where he founded the Cancer Therapy Development Program. Dr. Rosen received his Medical Degree from Baylor College of Medicine in Houston, Texas, his B.A. in English Literature from Yale University and Masters of Public Policy (M.P.P.) from Harvard University’s John F. Kennedy School of Government. Dr. Rosen is the principal investigator of many clinical trials that focus on new cancer drug development (phase I), particularly the treatment of gastrointestinal malignancies. He is also involved in translational projects with angiogenesis inhibitors, signal transduction inhibitors and new drug combinations. His work with angiogenesis inhibitors goes back to 1996 and he has since treated over 400 patients with nearly a dozen drugs in this class. The author of several papers, review articles and abstracts, he serves as an occasional reviewer for the Journal of Clinical Oncology, the Journal of the National Cancer Institute and Clinical Cancer Research, among others. Over the past couple of years, Premiere Oncology has expanded to partnerships in Scottsdale, Arizona and the San Diego metropolitan area.